Yes, eplerenone tablets can be carried in your hand luggage, but keep them in the original container with the label intact. If you are traveling to a country with strict drug-import regulations, carry a copy of the prescription or a physician’s letter.
Eplerenone is not a controlled substance and is not screened for in standard employment drug tests. It will not be reported as a positive result.
In Hong Kong, the 25 mg tablet is typically white, round, and imprinted with “25 EPL”. The 50 mg tablet is often orange, oval, and imprinted with “50 EPL”. Appearance may vary by manufacturer.
Both are aldosterone antagonists, but eplerenone is more selective for the mineralocorticoid receptor, leading to fewer anti-androgen side effects such as gynecomastia. Spironolactone has broader hormonal activity and a higher incidence of hormonal side effects.
Eplerenone is not prohibited by the World Anti-Doping Agency (WADA) and is generally permitted for athletes. However, any medication affecting electrolyte balance should be disclosed to the team physician.
A low-potassium diet can help mitigate the risk of hyper-kalemia, especially if you have borderline potassium levels. Discuss dietary adjustments with a dietitian or your prescriber.
Take the missed dose as soon as you remember, unless it is almost time for the next dose. Do not double the dose. Continue following your prescribed low-salt diet, as it works synergistically with eplerenone to control blood pressure.
Yes, several local pharmaceutical companies manufacture generic eplerenone tablets in the approved 25 mg and 50 mg strengths, all subject to Ministry of Health quality standards.
St. John’s wort is a CYP3A4 inducer and may lower eplerenone plasma concentrations, potentially reducing its effectiveness. Inform your healthcare provider about all herbal products you use.
A standard prescription bottle contains 30 tablets. If taken once daily, it will last approximately one month. Adjustments in dosing frequency or missed doses will alter the duration.
This article covers eplerenone, available as a generic medication and marketed under brand names such as Inspra. Eplerenone belongs to the heart & blood pressure therapeutic class and is supplied as a pill in 25 mg and 50 mg strengths. In Hong Kong, eplerenone is a prescription-only product regulated by the Department of Health.
Eplerenone is a selective aldosterone antagonist. Aldosterone is a hormone that signals the kidneys to retain sodium and water while excreting potassium. By blocking the aldosterone receptor in the distal nephron, eplerenone reduces sodium and water re-absorption and promotes potassium retention.
By dampening the effects of aldosterone, eplerenone helps lower blood pressure, reduces fluid overload, and lessens the strain on a failing heart.
These indications are approved by regulatory agencies, including the Hong Kong Department of Health. The medication is typically prescribed for adults who have stable kidney function and normal baseline potassium levels.
No strong peer-reviewed evidence supports routine off-label use of eplerenone beyond the approved indications. If a clinician considers an off-label application, it must be done under close medical supervision with a clear risk-benefit assessment.
Major interactions:
ACE inhibitors / ARBs - additive potassium-raising effect; monitor serum potassium and renal function.
Potassium-sparing diuretics (e.g., spironolactone, amiloride) - risk of marked hyper-kalemia.
Cytochrome P450 3A4 inhibitors (e.g., ketoconazole, clarithromycin) - may increase eplerenone levels; dose adjustment may be needed.
Moderate interactions:
NSAIDs (ibuprofen, naproxen) - can reduce renal clearance and raise potassium.
Trimethoprim-sulfamethoxazole - modest potassium increase; monitor labs.
Patients should disclose all prescription medications, over-the-counter drugs, supplements, and herbal products to their healthcare provider before starting eplerenone.
Promptly report any new weakness, palpitations, or markedly elevated potassium levels to a healthcare provider.
This article provides educational information about eplerenone and is not a substitute for professional medical advice. Treatment decisions, including use for unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.
